Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Penciclovir Market Growth 2022-2028

  • LP 4881465
  • 98 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Penciclovir will have significant change from previous year. According to our (LP Information) latest study, the global Penciclovir market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Penciclovir market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Penciclovir market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Penciclovir market, reaching US$ million by the year 2028. As for the Europe Penciclovir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Penciclovir players cover Novartis, BLDpharm, 3Waypharm, and Merck KGaA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Penciclovir market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Cream

Liquid

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novartis

BLDpharm

3Waypharm

Merck KGaA

BOC Sciences

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Penciclovir Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Penciclovir by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Penciclovir by Country/Region, 2017, 2022 & 2028

2.2 Penciclovir Segment by Type

2.2.1 Cream

2.2.2 Liquid

2.3 Penciclovir Sales by Type

2.3.1 Global Penciclovir Sales Market Share by Type (2017-2022)

2.3.2 Global Penciclovir Revenue and Market Share by Type (2017-2022)

2.3.3 Global Penciclovir Sale Price by Type (2017-2022)

2.4 Penciclovir Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Penciclovir Sales by Application

2.5.1 Global Penciclovir Sale Market Share by Application (2017-2022)

2.5.2 Global Penciclovir Revenue and Market Share by Application (2017-2022)

2.5.3 Global Penciclovir Sale Price by Application (2017-2022)

3 Global Penciclovir by Company

3.1 Global Penciclovir Breakdown Data by Company

3.1.1 Global Penciclovir Annual Sales by Company (2020-2022)

3.1.2 Global Penciclovir Sales Market Share by Company (2020-2022)

3.2 Global Penciclovir Annual Revenue by Company (2020-2022)

3.2.1 Global Penciclovir Revenue by Company (2020-2022)

3.2.2 Global Penciclovir Revenue Market Share by Company (2020-2022)

3.3 Global Penciclovir Sale Price by Company

3.4 Key Manufacturers Penciclovir Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Penciclovir Product Location Distribution

3.4.2 Players Penciclovir Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Penciclovir by Geographic Region

4.1 World Historic Penciclovir Market Size by Geographic Region (2017-2022)

4.1.1 Global Penciclovir Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Penciclovir Annual Revenue by Geographic Region

4.2 World Historic Penciclovir Market Size by Country/Region (2017-2022)

4.2.1 Global Penciclovir Annual Sales by Country/Region (2017-2022)

4.2.2 Global Penciclovir Annual Revenue by Country/Region

4.3 Americas Penciclovir Sales Growth

4.4 APAC Penciclovir Sales Growth

4.5 Europe Penciclovir Sales Growth

4.6 Middle East & Africa Penciclovir Sales Growth

5 Americas

5.1 Americas Penciclovir Sales by Country

5.1.1 Americas Penciclovir Sales by Country (2017-2022)

5.1.2 Americas Penciclovir Revenue by Country (2017-2022)

5.2 Americas Penciclovir Sales by Type

5.3 Americas Penciclovir Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Penciclovir Sales by Region

6.1.1 APAC Penciclovir Sales by Region (2017-2022)

6.1.2 APAC Penciclovir Revenue by Region (2017-2022)

6.2 APAC Penciclovir Sales by Type

6.3 APAC Penciclovir Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Penciclovir by Country

7.1.1 Europe Penciclovir Sales by Country (2017-2022)

7.1.2 Europe Penciclovir Revenue by Country (2017-2022)

7.2 Europe Penciclovir Sales by Type

7.3 Europe Penciclovir Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Penciclovir by Country

8.1.1 Middle East & Africa Penciclovir Sales by Country (2017-2022)

8.1.2 Middle East & Africa Penciclovir Revenue by Country (2017-2022)

8.2 Middle East & Africa Penciclovir Sales by Type

8.3 Middle East & Africa Penciclovir Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Penciclovir

10.3 Manufacturing Process Analysis of Penciclovir

10.4 Industry Chain Structure of Penciclovir

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Penciclovir Distributors

11.3 Penciclovir Customer

12 World Forecast Review for Penciclovir by Geographic Region

12.1 Global Penciclovir Market Size Forecast by Region

12.1.1 Global Penciclovir Forecast by Region (2023-2028)

12.1.2 Global Penciclovir Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Penciclovir Forecast by Type

12.7 Global Penciclovir Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Penciclovir Product Offered

13.1.3 Novartis Penciclovir Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 BLDpharm

13.2.1 BLDpharm Company Information

13.2.2 BLDpharm Penciclovir Product Offered

13.2.3 BLDpharm Penciclovir Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BLDpharm Main Business Overview

13.2.5 BLDpharm Latest Developments

13.3 3Waypharm

13.3.1 3Waypharm Company Information

13.3.2 3Waypharm Penciclovir Product Offered

13.3.3 3Waypharm Penciclovir Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 3Waypharm Main Business Overview

13.3.5 3Waypharm Latest Developments

13.4 Merck KGaA

13.4.1 Merck KGaA Company Information

13.4.2 Merck KGaA Penciclovir Product Offered

13.4.3 Merck KGaA Penciclovir Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck KGaA Main Business Overview

13.4.5 Merck KGaA Latest Developments

13.5 BOC Sciences

13.5.1 BOC Sciences Company Information

13.5.2 BOC Sciences Penciclovir Product Offered

13.5.3 BOC Sciences Penciclovir Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 BOC Sciences Main Business Overview

13.5.5 BOC Sciences Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Penciclovir Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Penciclovir Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cream

Table 4. Major Players of Liquid

Table 5. Global Penciclovir Sales by Type (2017-2022) & (K Units)

Table 6. Global Penciclovir Sales Market Share by Type (2017-2022)

Table 7. Global Penciclovir Revenue by Type (2017-2022) & ($ million)

Table 8. Global Penciclovir Revenue Market Share by Type (2017-2022)

Table 9. Global Penciclovir Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Penciclovir Sales by Application (2017-2022) & (K Units)

Table 11. Global Penciclovir Sales Market Share by Application (2017-2022)

Table 12. Global Penciclovir Revenue by Application (2017-2022)

Table 13. Global Penciclovir Revenue Market Share by Application (2017-2022)

Table 14. Global Penciclovir Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Penciclovir Sales by Company (2020-2022) & (K Units)

Table 16. Global Penciclovir Sales Market Share by Company (2020-2022)

Table 17. Global Penciclovir Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Penciclovir Revenue Market Share by Company (2020-2022)

Table 19. Global Penciclovir Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Penciclovir Producing Area Distribution and Sales Area

Table 21. Players Penciclovir Products Offered

Table 22. Penciclovir Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Penciclovir Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Penciclovir Sales Market Share Geographic Region (2017-2022)

Table 27. Global Penciclovir Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Penciclovir Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Penciclovir Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Penciclovir Sales Market Share by Country/Region (2017-2022)

Table 31. Global Penciclovir Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Penciclovir Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Penciclovir Sales by Country (2017-2022) & (K Units)

Table 34. Americas Penciclovir Sales Market Share by Country (2017-2022)

Table 35. Americas Penciclovir Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Penciclovir Revenue Market Share by Country (2017-2022)

Table 37. Americas Penciclovir Sales by Type (2017-2022) & (K Units)

Table 38. Americas Penciclovir Sales Market Share by Type (2017-2022)

Table 39. Americas Penciclovir Sales by Application (2017-2022) & (K Units)

Table 40. Americas Penciclovir Sales Market Share by Application (2017-2022)

Table 41. APAC Penciclovir Sales by Region (2017-2022) & (K Units)

Table 42. APAC Penciclovir Sales Market Share by Region (2017-2022)

Table 43. APAC Penciclovir Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Penciclovir Revenue Market Share by Region (2017-2022)

Table 45. APAC Penciclovir Sales by Type (2017-2022) & (K Units)

Table 46. APAC Penciclovir Sales Market Share by Type (2017-2022)

Table 47. APAC Penciclovir Sales by Application (2017-2022) & (K Units)

Table 48. APAC Penciclovir Sales Market Share by Application (2017-2022)

Table 49. Europe Penciclovir Sales by Country (2017-2022) & (K Units)

Table 50. Europe Penciclovir Sales Market Share by Country (2017-2022)

Table 51. Europe Penciclovir Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Penciclovir Revenue Market Share by Country (2017-2022)

Table 53. Europe Penciclovir Sales by Type (2017-2022) & (K Units)

Table 54. Europe Penciclovir Sales Market Share by Type (2017-2022)

Table 55. Europe Penciclovir Sales by Application (2017-2022) & (K Units)

Table 56. Europe Penciclovir Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Penciclovir Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Penciclovir Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Penciclovir Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Penciclovir Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Penciclovir Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Penciclovir Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Penciclovir Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Penciclovir Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Penciclovir

Table 66. Key Market Challenges & Risks of Penciclovir

Table 67. Key Industry Trends of Penciclovir

Table 68. Penciclovir Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Penciclovir Distributors List

Table 71. Penciclovir Customer List

Table 72. Global Penciclovir Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Penciclovir Sales Market Forecast by Region

Table 74. Global Penciclovir Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Penciclovir Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Penciclovir Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Penciclovir Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Penciclovir Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Penciclovir Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Penciclovir Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Penciclovir Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Penciclovir Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Penciclovir Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Penciclovir Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Penciclovir Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Penciclovir Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Penciclovir Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Penciclovir Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Penciclovir Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Penciclovir Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Penciclovir Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novartis Basic Information, Penciclovir Manufacturing Base, Sales Area and Its Competitors

Table 93. Novartis Penciclovir Product Offered

Table 94. Novartis Penciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Novartis Main Business

Table 96. Novartis Latest Developments

Table 97. BLDpharm Basic Information, Penciclovir Manufacturing Base, Sales Area and Its Competitors

Table 98. BLDpharm Penciclovir Product Offered

Table 99. BLDpharm Penciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. BLDpharm Main Business

Table 101. BLDpharm Latest Developments

Table 102. 3Waypharm Basic Information, Penciclovir Manufacturing Base, Sales Area and Its Competitors

Table 103. 3Waypharm Penciclovir Product Offered

Table 104. 3Waypharm Penciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. 3Waypharm Main Business

Table 106. 3Waypharm Latest Developments

Table 107. Merck KGaA Basic Information, Penciclovir Manufacturing Base, Sales Area and Its Competitors

Table 108. Merck KGaA Penciclovir Product Offered

Table 109. Merck KGaA Penciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Merck KGaA Main Business

Table 111. Merck KGaA Latest Developments

Table 112. BOC Sciences Basic Information, Penciclovir Manufacturing Base, Sales Area and Its Competitors

Table 113. BOC Sciences Penciclovir Product Offered

Table 114. BOC Sciences Penciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. BOC Sciences Main Business

Table 116. BOC Sciences Latest Developments

List of Figures

Figure 1. Picture of Penciclovir

Figure 2. Penciclovir Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Penciclovir Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Penciclovir Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Penciclovir Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cream

Figure 10. Product Picture of Liquid

Figure 11. Global Penciclovir Sales Market Share by Type in 2021

Figure 12. Global Penciclovir Revenue Market Share by Type (2017-2022)

Figure 13. Penciclovir Consumed in Hospital

Figure 14. Global Penciclovir Market: Hospital (2017-2022) & (K Units)

Figure 15. Penciclovir Consumed in Clinic

Figure 16. Global Penciclovir Market: Clinic (2017-2022) & (K Units)

Figure 17. Penciclovir Consumed in Others

Figure 18. Global Penciclovir Market: Others (2017-2022) & (K Units)

Figure 19. Global Penciclovir Sales Market Share by Application (2017-2022)

Figure 20. Global Penciclovir Revenue Market Share by Application in 2021

Figure 21. Penciclovir Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Penciclovir Revenue Market Share by Company in 2021

Figure 23. Global Penciclovir Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Penciclovir Revenue Market Share by Geographic Region in 2021

Figure 25. Global Penciclovir Sales Market Share by Region (2017-2022)

Figure 26. Global Penciclovir Revenue Market Share by Country/Region in 2021

Figure 27. Americas Penciclovir Sales 2017-2022 (K Units)

Figure 28. Americas Penciclovir Revenue 2017-2022 ($ Millions)

Figure 29. APAC Penciclovir Sales 2017-2022 (K Units)

Figure 30. APAC Penciclovir Revenue 2017-2022 ($ Millions)

Figure 31. Europe Penciclovir Sales 2017-2022 (K Units)

Figure 32. Europe Penciclovir Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Penciclovir Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Penciclovir Revenue 2017-2022 ($ Millions)

Figure 35. Americas Penciclovir Sales Market Share by Country in 2021

Figure 36. Americas Penciclovir Revenue Market Share by Country in 2021

Figure 37. United States Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Penciclovir Sales Market Share by Region in 2021

Figure 42. APAC Penciclovir Revenue Market Share by Regions in 2021

Figure 43. China Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Penciclovir Sales Market Share by Country in 2021

Figure 50. Europe Penciclovir Revenue Market Share by Country in 2021

Figure 51. Germany Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Penciclovir Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Penciclovir Revenue Market Share by Country in 2021

Figure 58. Egypt Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Penciclovir Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Penciclovir in 2021

Figure 64. Manufacturing Process Analysis of Penciclovir

Figure 65. Industry Chain Structure of Penciclovir

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390